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Abstract
Background: In murine models of malaria, an early proinflammatory response has been associated with
the resolution of blood-stage infection. To dissect the protective immune mechanims that allow the
control of parasitaemia, the early immune response of C57BL/6 mice induced during a non-lethal
plasmodial infection was analysed.
Methods: Mice were infected with Plasmodium yoelii 265BY sporozoites, the natural invasive form of the
parasite, in order to complete its full life cycle. The concentrations of three proinflammatory cytokines in
the sera of mice were determined by ELISA at different time points of infection. The contribution of the
liver and the spleen to this cytokinic response was evaluated and the cytokine-producing lymphocytes
were identified by flow cytometry. The physiological relevance of these results was tested by monitoring
parasitaemia in genetically deficient C57BL/6 mice or wild-type mice treated with anti-cytokine neutralizing
antibody. Finally, the cytokinic response in sera of mice infected with parasitized-RBCs was analysed.
Results: The early immune response of C57BL/6 mice to sporozoite-induced malaria is characterized by
a peak of IFN-γ in the serum at day 5 of infection and splenic CD4 T lymphocytes are the major producer
of this cytokine at this time point. Somewhat unexpected, the parasitaemia is significantly lower in P. yoelii-
infected mice in the absence of IFN-γ. More precisely, at early time points of infection, IFN-γ favours
parasitaemia, whereas helping to clear efficiently the blood-stage parasites at later time points.
Interestingly, the early IFN-γ burst is induced by the pre-erythrocytic stage.
Conclusion: These results challenge the current view regarding the role of IFN-γ on the control of
parasite growth since they show that IFN-γ is not an essential mediator of protection in P. yoelii-infected
C57BL/6 mice. Moreover, the mice parasitaemia is more efficiently controlled in the absence of an early
IFN-γ production, suggesting that this cytokine promotes parasite's growth. Finally, this early burst of IFN-
γ is induced by the pre-erythrocytic stage, showing the impact of this stage on the immune response taking
place during the subsequent erythrocytic stage.
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Background
Malaria is initiated when sporozoites are injected into the
mammalian host during the blood meal of an infected
mosquito. The sporozoites reach the liver where they
mature and divide within hepatocytes, thus completing
the first phase of the parasite life cycle, the pre-erythro-
cytic stage. When the hepatic forms are mature, thousands
of merozoites are released, reach the blood stream and
invade red blood cells, initiating the erythrocytic stage.
Parasitized RBCs (pRBCs) subsequently release new
merozoites, which perpetuate the erythrocytic cycle by
invading new RBCs.
In mice, as well as in humans, early immune events play a
determinant role in the outcome of malaria, which
depends, in part, on a subtle balance between pro- and
anti-inflammatory responses. An early proinflammatory
immune response has not only been associated with pro-
tection, through its contribution to parasite elimination,
but also with the severe complications of the disease [1-3].
In murine models of malaria, the early production of IL-
12, IL-18, TNF and IFN-γ has been associated with the res-
olution of blood-stage infection [1,4-6]. Particularly, an
early IFN-γ production was shown to be essential to con-
trol parasitaemia and to be associated with a better sur-
vival prognostic [7-9]. IFN-γ indeed promotes protective
Th1 T cell responses in vivo, and favours the Th1-associ-
ated IgG2a response involved in the clearance of blood-
stage parasites [9].
Recently, NK, NKT, and γδT cells were shown to produce
IFN-γ during the blood-stage of murine malaria and also
in response to P. falciparum-infected RBCs in vitro [3,10-
12].
To better define the early immune mechanisms that pro-
mote the control of Plasmodium growth and its elimina-
tion during primary infection, the non-lethal malaria
model of B6 mice infected with P. yoelii 265BY sporo-
zoites, the natural invasive form of the parasite, was used.
Such an experimental condition allows the development
in vivo of the full Plasmodium life cycle that is closer to the
natural infection.
In this model, the production of Th1 cytokines in vivo was
first analysed at early post-infection (p.i.) time points.
This showed that P. yoelii 265BY infection in B6 mice is
characterized by a peak of IFN-γ in the serum at day 5 p.i.,
while concentrations of circulating TNF and IL-12 stayed
at the levels found in non-infected animals. Flow cytomet-
ric analyses revealed that splenic NKT, NK, γδ and CD4 T
cells simultaneously produced this cytokine at day 5 p.i.,
the latter ones being the major producer. Then, B6.IFN-γ-/
- mice were used to evaluate the physiological relevance of
this early IFN-γ production on the control of infection in
vivo. Surprisingly, the parasitaemia of infected B6.IFN-γ-/-
was significantly lower than the one of B6 mice. These
results were confirmed by in vivo neutralization of the
early production of IFN-γ in infected B6 mice using anti-
IFN-γ Abs. Finally, the stage-specificity of this early IFN-γ
burst was addressed and, following infection of B6 mice
with P. yoelii-infected RBCs, no peak of IFN-γ was detecta-
ble in their serum during the first week of infection.
In conclusion, these results show that, during a primary
infection initiated with P. yoelii sporozoites, IFN-γ plays
two opposite roles in the control of parasitaemia and that,
unexpectedly, B6 mice control their parasitaemia better in
the absence of an early IFN-γ production. Together with a
recent report from Couper et al [13], the results presented
here challenge the current view regarding the role of IFN-
γ on the control of the parasite growth and suggest that an
early peak of circulating IFN-γ promotes Plasmodium's
growth during a primary infection. In addition to that,
these data show that the immune response induced by the
pre-erythrocytic stage impacts on the control of the subse-
quent erythrocytic stage. These results highlight the
importance of studying the immune response to Plasmo-
dium in models as close as possible to the physiology of
the natural infection.
Methods
Mice
C57Bl/6N@Ico (referred to as B6) mice were purchased
from Charles River-Iffa Credo (St-Aubin les Elbeufs,
France). CD1d.1-/-, IFN-γ-/- and RAG2-/- mice on a C57BL/
6 genetic background were provided by A. Bendelac [14],
J.F. Bureau (mice bred at the Institut Pasteur, originally
from the Jackson Laboratory, Bar Harbor, Maine, USA),
and J.P. Di Santo [15] respectively (referred to as
B6.CD1d-/-, B6. IFN-γ-/- and B6.RAG2-/-). All animals were
housed and bred in the animal facilities of the Institut Pas-
teur (Paris, France) under standard conditions. Only 8- to
12-week-old females were used and experiments were
conducted in accordance with institutional guidelines for
animal care and use.
Parasites, in vivo infection, and parasitaemia
Sporozoites of the uncloned line of the 265BY strain of
Plasmodium yoelii yoelii were obtained by dissecting the sal-
ivary glands of infected Anopheles stephensi mosquitoes as
previously described [16]. The mosquitoes were bred,
maintained, and infected at the CEPIA (Centre de Produc-
tion et Infection des Anophèles, Institut Pasteur, Paris,
France). Mice were infected intravenously with 4,000 spo-
rozoites diluted in sterile PBS or intraperitoneally with
106 parasitized-RBCs (pRBCs). Parasitaemia was meas-
ured by flow cytometry following a protocol adapted from
Jouin et al [17,18], and Lee et al [19]. Briefly, 3 μl of bloodMalaria Journal 2009, 8:128 http://www.malariajournal.com/content/8/1/128
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taken from the tail vein were fixed in 500 μl of PBS-glutar-
aldehyde 0.25% (grade I, ref. G5882, Sigma Aldrich,
Lyon, France) and stored at 4°C until use. Once all the
samples were collected, 50 μl of each were incubated in
400 μl of PBS containing 0.5 mM Hoechst (Bisbenzimide
H33258, ref. B 2883, Sigma Aldrich) and 0.1 mg/ml Thi-
azole Orange (ref. 39 006.2, Sigma Aldrich) for 1 hour, at
RT, in the dark. Analysis of the staining was performed on
a LSR cytometer using the CellQuest Pro software (BD
Biosciences, San Diego, California, USA). Results are
expressed as the percentage of pRBCs.
Isolation of hepatic and splenic mononuclear cells
Hepatic mononuclear cells were prepared as previously
described [20]. Briefly, livers from control and infected
mice were perfused in situ with sterile DMEM, removed
and homogenized using a Potter-Elvehjem homogenizer.
Cells were washed, resuspended in a 35% Percoll solution
(Pharmacia Biotech, Uppsala, Sweden) and centrifuged at
1400 g for 25 min at room temperature (RT). The pellet
(containing mononuclear cells) was washed with DMEM.
Spleens from control and infected mice were gently
smashed between two glass slides in sterile D-MEM
(Gibco Invitrogen, Cergy Pontoise, France). The cell sus-
pensions were then washed with D-MEM before erythro-
cyte lysis with an ACK lysing buffer (0.15 M NH4Cl, 10
mM KHCO3, 0.1 mM Na2EDTA). Finally, cells were resus-
pended in sterile RPMI 1640 medium + GlutaMAX I
(Gibco Invitrogen) containing 3% FCS before counting of
living cells in eosin.
Intracellular cytokine staining for flow cytometric analysis
Splenic cells from control and infected mice were isolated
and incubated at a concentration of 1 × 106 cells per ml,
for 1 hour at 37°C in a 5% CO2 atmosphere, in RPMI
1640 medium + GlutaMAX I containing 10% FCS, penicil-
lin-streptomycin (100 IU/ml, Gibco Invitrogen), and
brefeldin A (10 μg/ml, Sigma Aldrich). Cells were then
washed once in PBS-3% FCS and surface antigens were
stained at 4°C, in the dark, for 20 min, using the follow-
ing monoclonal antibodies purchased from BD Bio-
sciences and conjugated to biotine, FITC, PE, APC or PE-
cyanine7: anti-NK1.1 (PK136), anti-TCRγδ (GL3), anti-
CD3ε (145-2C11), anti-CD4 (L3T4), anti-CD8α (Ly-2).
Biotinylated mAbs were revealed with streptavidine-PE-
cyanine7 (BD Biosciences). Then, cells were fixed for one
hour at RT, in the dark, with 2% PFA, and subsequently
treated with Perm/Wash solution (BD Biosciences) before
incubation with APC-conjugated anti-IFN-γ (XMG1.2, BD
Biosciences) or isotype-matched control mAb (rat IgG1,
BD Biosciences) in Perm/Wash solution at RT, in the dark,
for 30 min. Finally, cells were washed in Perm/Wash solu-
tion and then in PBS-3% FCS. Stained cells were analysed
on a six-color LSR flow cytometer with the CellQuest Pro
software (BD Biosciences, San Diego, CA).
Quantification of cytokines in the sera and in culture 
supernatants by ELISA
Mice were bled at the indicated days and sera were aliq-
uoted and stored at -20°C until use. The mouse IFN-γ
ELISA Set (Cat. No. 555138), mouse TNF (Mono/Mono)
ELISA Set (Cat. No. 555268), and mouse IL-12p40 ELISA
Set (Cat. No. 555165) from BD Biosciences were used to
quantify each cytokine following the manufacturer's
instructions. Duplicate serial dilutions were performed for
each serum, and DO means were used to determine the
concentrations of cytokines in the samples according to
the standard.
For quantification of IFN-γ in culture supernatants, total
splenocytes and iHLs were isolated, resuspended at a con-
centration of 1 × 106 cells/ml in complete RPMI 1640
GlutaMAX I (10% FCS, 100 IU/ml penicillin-streptomy-
cin) and distributed at 200 μl/well in 96-well tissue cul-
ture plates. Duplicate cultures were done for each sample.
After 72 hours of culture, plates were centrifuged, 150 μl
of supernatants were collected and stored frozen at -20°C
until use. DO means of duplicate wells were used to deter-
mine the concentration of IFN-γ in the samples according
to the standard.
In vivo treatment of C57Bl/6 mice with anti-IFN-γ mAb
Mice were infected with 4,000 sporozoites and, on the
indicated day, were injected intraperitoneally with 2 mg
of anti-IFN-γ mAb (XMG1.2, purified from ascites fluid by
DEAE cellulose) or with 2 mg of irrelevant control rat IgG
(ref. I4131, Sigma).
Statistical analyses
Statistical analyses were performed using the non-para-
metric Mann-Whitney test and Statview 5.0 software (SAS
Institute Inc., Cary, NC). A p-value < 0.05 was considered
significant.
Results
Plasmodium yoelii sporozoite infection induces an early 
peak of IFN-γ in the serum of B6 mice
The  in vivo production of three Th1-type cytokines,
namely IFN-γ, TNF and IL-12, during P. yoelii primary
infection in B6 mice was first adressed. For that purpose,
the concentrations of these cytokines in the sera of non-
infected and infected mice were determined by ELISA,
between day 3 and day 10 post-injection of sporozoites.
TNF and IL-12 concentrations did not change during the
course of infection and remained at the level found in
non-infected control mice.
Conversely, the concentration of IFN-γ peaked at day 5 p.i.
(Figure 1; median value at day 5 p.i. = 11.51 ng/ml, n = 21;
median value in non-infected control mice = 1.66 ng/ml,
n = 22; p < 0.0001). A large range of IFN-γ concentrationsMalaria Journal 2009, 8:128 http://www.malariajournal.com/content/8/1/128
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at day 5 p.i. was observed among mice, which could be
explained by the transient nature of IFN-γ production. No
increase in the IFN-γ concentration was detected in the
sera of mice 5 days after injection of salivary gland extracts
from non-infected mosquitoes (NiSG, Figure 1). This
result shows that the peak of IFN-γ observed at day 5 p.i.
is not the result of a non-specific immune response
induced by salivary gland extracts, but is specifically
induced by P. yoelii infection. This peak of IFN-γ was
absent from the sera of B6.IFN-γ-/- mice. Thus, P. yoelii pri-
mary infection in B6 mice, induced by the injection of
sporozoites, is characterized by a peak of IFN-γ in the
blood at day 5 of infection.
The early peak of IFN-γ in the serum is dependent on T 
and/or B lymphocytes, but independent of CD1d-restricted 
NKT cells
To identify the lymphoid cell populations involved in this
early IFN-γ production, sera of B6.RAG2-/- mice (which
lack T, B, and NKT cells, but possess NK cells) were tested
by ELISA. No peak of IFN-γ was detected in the sera of
these mice between day 0 and day 10 p.i. (Figure 2), dem-
onstrating that this early production of IFN-γ is dependent
on T, and/or B, and/or NKT lymphocytes. Moreover, these
results suggest that NK cells alone cannot initiate the pro-
duction of this cytokine at a level detectable in the serum.
Since this burst of IFN-γ occurs early after parasite injec-
tion, it was postulated that other innate lymphocytes
could be the source of this cytokine. In this context,
involvement of CD1d-restricted NKT cells, a population
Primary infection of B6 mice with P. yoelii sporozoites is characterized by a peak of IFN-γ in the sera at day 5 post-infection Figure 1
Primary infection of B6 mice with P. yoelii sporozoites is characterized by a peak of IFN-γ in the sera at day 5 
post-infection. B6 mice were infected with 4,000 sporozoites of P. yoelii 265BY and the serum level of IFN-γ at days 0, 3, 4, 5, 
6, 7, and 10 p.i. was determined by ELISA. Results from a pool of 6 independent experiments (3 to 21 mice per time point) are 
shown. Individual values (circles) and mean values (bars) are shown. NiSG: day-5 serum from B6 mice which received an injec-
tion of non-infected salivary gland extract. The statistical difference between day 0 (n = 17) and day 5 p.i. (n = 21) was calcu-
lated with the Mann-Whitney test.Malaria Journal 2009, 8:128 http://www.malariajournal.com/content/8/1/128
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of lymphocytes involved in early immune responses to
several pathogens, including Plasmodium [21-23], was
tested. B6.CD1d-/- mice, which lack CD1d-restricted NKT
cells, were infected and IFN-γ in serum was quantified by
ELISA at different time points p.i. As shown in Figure 2,
the IFN-γ concentration in the sera of B6.CD1d-/- mice
increased at day 5 p.i. and reached a similar amount to
that detected in day 5-infected B6 mice (B6.CD1d-/-
median value at day 5 p.i. = 6.760 ng/ml, n = 10; B6
median value at day 5 p.i. = 11.51 ng/ml, n = 21; p =
0.3932). At days 3, 4, 6, and 7 p.i., IFN-γ concentrations
determined in the sera of B6.CD1d-/- mice were similar to
those found in non-infected mice. Thus, these results
show that CD1d-restricted NKT cells are not necessary for
the initiation of the IFN-γ burst detected in the serum at
day 5 p.i.
Splenocytes are the major source of IFN-γ at early time 
points of P. yoelii infection
Since it has previously been observed that the innate
immune response to P. yoelii infection was compartimen-
talised and differed between spleen and liver [11,12], the
contribution of splenocytes and iHLs to this production
of IFN-γ in B6 mice was analysed at days 0 and 5 pi.
Splenic and hepatic cells were isolated and IFN-γ was
quantified in supernatants after 72 h of culture without
any stimulation. As shown in Figure 3A, the concentration
of IFN-γ was significantly increased in supernatants of
both splenocytes and iHLs isolated from day 5-infected B6
mice. In addition, splenocytes and iHLs produced compa-
rable amounts of IFN-γ for a similar number of cells per
culture well (Figure 3A). However, the number of total
splenocytes at day 5 of infection was about 60 times
higher than the one of total iHLs. So, considering the IFN-
γ production that can be attributed to each organ, the
spleen appeared to be the main source of IFN-γ (Figure
3B). Consequently, further analyses were focussed on this
organ.
Splenic conventional T CD4 lymphocytes are the major 
producers of IFN-γ at day 5 p.i
In order to precise the cellular source of IFN-γ among
splenocytes, the intracellular production of this cytokine
by splenic NK cells, NKT cells, γδ CD4 and CD8 T cells
during infection was analysed by flow cytometry. Exam-
ples of FACS analysis for minor lymphocyte populations
are shown in Figure 4A. As shown in Figure 4B, the pro-
portion of IFN-γ-positive cells among NKT, NK, and γδT
cells peaked at day 5 p.i., matching with the peak of this
cytokine detected in the sera. It can also be noted that the
frequency of IFN-γ-positive cells decreases very rapidly
after day 5 of infection, except for NKT cells. In parallel,
the percentage of IFN-γ-positive conventional CD4T cells
started to increase from day 5 p.i. and was maintained sta-
ble, at least, until day 7 p.i. (Figure 4B).
However, the number of splenic CD4 T cells secreting IFN-
γ at day 5 p.i. was 2.4 and 2.5 times superior to the num-
bers of IFN-γ-positive innate lymphocytes and CD8 T
cells, respectively (Figure 4C). Thus, the production of
IFN-γ by splenic innate lymphocytes is simultaneous and
peaks at day 5 p.i., but conventional CD4 T cells represent
the major source of this cytokine at this time point.
Absence of the early production of IFN-γ associates with a 
better control of parasitaemia
Then, the physiological relevance of this early burst of
IFN-γ in the control of infection was addressed. B6 and
B6.IFN-γ-/- mice were infected with sporozoites and their
survival and parasitaemia were monitored. As shown in
Figure 5A, B6.IFN-γ-/- mice survived the infection as well as
B6 control mice. The parasitaemia of B6.IFN-γ-/- mice was
The early peak of IFN-γ in the serum of P. yoelii-infected mice  is dependent on T and/or B lymphocytes, but independent of  CD1d-dependent NKT cells Figure 2
The early peak of IFN-γ in the serum of P. yoelii-
infected mice is dependent on T and/or B lym-
phocytes, but independent of CD1d-dependent NKT 
cells. B6.RAG2-/- mice and B6.CD1d-/- mice were infected 
with 4,000 sporozoites of P. yoelii 265BY and the serum level 
of IFN-γ at days 0 and 5 p.i. was determined by ELISA. 
Results from a pool of 2 to 3 independent experiments per 
mouse strain (4 to 17 mice per time point) are shown. Indi-
vidual values (circles) and mean values (bars) are shown. The 
statistical difference between day 0 (n = 8 B6.CD1d-/-) and 
day 5 p.i. (n = 10 B6.CD1d-/-) was calculated with the Mann-
Whitney test.Malaria Journal 2009, 8:128 http://www.malariajournal.com/content/8/1/128
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Splenocytes are the major source of IFN-γ ex vivo Figure 3
Splenocytes are the major source of IFN-γ ex vivo. B6 mice were either infected with 4,000 sporozoites of P. yoelii (n = 
10 mice) or received an injection of salivary gland extracts from non-infected mosquitoes (n = 10 NiSG control mice). Five 
days later, splenocytes and iHLs were isolated and cultured for 3 days without any stimulation. Then, supernatants were col-
lected and IFN-γ concentrations were determined by ELISA. A. Results are expressed as mean values ± SD of IFN-γ in pg per 
2.5 × 105 cells. B. Results are expressed as mean values ± SD of IFN-γ in ng per organ (meaning per total number of spleno-
cytes or iHLs at the indicated days p.i.). Data from a representative experiment out of two are shown.Malaria Journal 2009, 8:128 http://www.malariajournal.com/content/8/1/128
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Splenic NK, NKT, γδT and CD4 T lymphocytes produce IFN-γ simultaneously at day 5 p.i Figure 4
Splenic NK, NKT, γδT and CD4 T lymphocytes produce IFN-γ simultaneously at day 5 p.i. Splenocytes were iso-
lated from non-infected and infected B6 mice at days 4, 5, 6, and 7 after injection of 4,000 P. yoelii 265BY sporozoites. Intracel-
lular expression of IFN-γ among NK cells (gated on NK1.1+CD3-), NKT cells (gated on NK1.1+TCRβ+), γδT cells (gated on 
CD3+TCRγδ+), CD4 T cells (gated on CD4+) and CD8 T cells (gated on CD8+) cells was analysed by flow cytometry. A. FACS 
dot plots showing IFN-γ expression among splenic NK, NKT and γδT cells at days 0 and 5 p.i. IC: isotype-matched control anti-
body. Percentages of positive cells are indicated. B and C. Kinetics of intracellular IFN-γ expression among the different subsets 
of lymphocytes. Analysis was performed as shown in A. Results are expressed as mean values ± SD of the percentages (B) or 
the numbers (C) of IFN-γ-positive cells among each subset. Data are representative of two independent experiments with at 
least three mice per time point.Malaria Journal 2009, 8:128 http://www.malariajournal.com/content/8/1/128
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Parasitaemia of B6 mice is lower in the absence of IFN-γ during primary P. yoelii infection Figure 5
Parasitaemia of B6 mice is lower in the absence of IFN-γ during primary P. yoelii infection. A. Parasitaemia of B6 
control mice and B6.IFN-γ-/- mice following injection of 4,000 sporozoites of P. yoelii 265BY. B. Parasitaemia of B6 mice treated 
with either 2 mg of anti- IFN-γ mAb or 2 mg of rat control Ab, at day 3 p.i. with 4,000 sporozoites of P. yoelii 265BY. C. Parasi-
taemia of B6 mice treated with 2 mg of anti- IFN-γ mAb at day 4 p.i. with 4,000 sporozoites of P. yoelii 265BY. Regarding their 
parasitaemia curves, two groups of mice were identified: "high" and "low" parasitaemia. D. Parasitaemia of B6 and B6.IFN-γ-/- 
mice following injection of 106 P. yoelii 265BY pRBCs. Each graph is representative of two independent experiments with 3 to 9 
mice per time point. Results are expressed as mean value ± SD. The statistical differences between groups were determined 
with the Mann-Whitney test (* = p < 0.05).Malaria Journal 2009, 8:128 http://www.malariajournal.com/content/8/1/128
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significantly lower than that of B6 mice after day 8 of
infection. In addition, the duration of parasitaemia was
longer in B6. IFN-γ-/- mice than in control animals, as par-
asites were cleared from the blood only at day 32 p.i.,
compared to day 25 in B6 mice (Figure 5A).
To analyse more precisely the consequence of the early
peak of IFN-γ on the control of infection, a single injection
of anti-IFN-γ mAb was performed in B6 mice, at day 3 or
day 4 p.i., and their survival and parasitaemia were mon-
itored. As shown in Figure 5B, B6 mice treated at day 3 p.i.
with anti-IFN-γ mAb survived the same as control mice
which received irrelevant rat IgG, but their parasitaemia
rose significantly slower (since day 6 of infection), and
their peak of parasitaemia was significantly lower than
that of B6 control mice. However, in contrast to B6.IFN-γ-
/- mice, B6 mice treated with anti-IFN-γ mAb at day 3 p.i.
eliminated blood stage parasites at the same time as the
B6 mice which received irrelevant rat IgG (Figure 5B).
It is also interesting to note that B6 mice, which received
anti-IFN-γ mAb on day 4 of infection behaved differently.
Indeed, from three independent experiments, 36.8% (7
out of 19) of the mice behave like B6 mice treated at day
3 p.i. ("low parasitaemia" group; Figure 5C), and the
other mice displayed parasitaemia similar to that of B6
control mice ("high parasitaemia" group; Figure 5C). Ab
treatment at days 5 and 7 p.i. had no effect on the parasi-
taemia of B6 mice. This shows that the decrease in parasi-
taemia, observed between day 6 and day 20 p.i., is a
consequence of the neutralization of IFN-γ at days 3–4
p.i., and is not due to persistent anti-IFN-γ mAb, which
would have neutralized subsequent production of IFN-γ.
Altogether, these results clearly show that, in B6 mice,
IFN-γ is not essential to cure of P. yoelii primary infection
and to eliminate blood-stage parasites, but in its absence,
parasitaemia is delayed and lowered. In other models of
non-cerebral malaria, such as P. chabaudi infection, mice
are infected with pRBCs. As the results presented here
were unexpected compared to the ones observed in the
well-described  P. chabaudi model [8,9], the hypothesis
that the parasite stage used for infection could explain
these discrepancies was tested. To clarify this point, B6
and B6.IFN-γ-/- mice were infected with P. yoelii pRBCs and
their survival and parasitaemia were monitored. As shown
in Figure 5D, B6.IFN-γ-/- mice infected with pRBCs behave
in the same way as when infected with sporozoites: they
survived the infection, their parasitaemia was significantly
lower after day 9 of infection, and it lasted longer than
that of B6 mice. This shows that the results obtained are
not related to the parasite stage used to initiate the infec-
tion.
The early burst of IFN-γ is induced by the pre-erythrocytic 
stage of P. yoelii infection
Finally, in order to determine the parasite developmental
stage that induces the early peak of IFN-γ, B6 mice were
infected with P. yoelii-infected RBCs and the concentration
of IFN-γ was determined in their sera. No significant
increase of IFN-γ concentrations was observed in the sera
of mice at days 3, 4, 5, 6 and 7 post-injection of pRBCs
(two independent experiments). Moreover, the level of
IFN-γ stayed at the level found in non-infected animals,
excepted for two mice out of 36 infected, which showed a
small increase of IFN-γ in their serum (one out of five day-
3 mice had 4.98 ng/ml of IFN-γ, and one out of nine day
6-mice had 6.96 ng/ml of IFN-γ). These results clearly
indicate that the early IFN-γ burst is induced by the pre-
erythrocytic stage, and not by the blood-stage.
Discussion
The data presented here show that the immune response
of B6 mice to a P. yoelii primary infection initiated with
sporozoites is characterized by an early burst of IFN-γ,
dependent on the pre-erythrocytic stage.
Somewhat unexpectedly, IFN-γ was not essential to elimi-
nate blood-stage parasites, and moreover, mice controlled
their parasitaemia in a more effective manner in the
absence of this early burst of IFN-γ. These results are in
contradiction with other studies showing that IFN-γ con-
tributes to blood-stage clearance. Indeed, in the well-
described P. chabaudi model, IFN-γ-deficient mice infected
with pRBCs control their parasitaemia less efficiently and
die from infection [6,8,9]. This discrepancy cannot be
attributed to the parasite stage used to initiate the infec-
tion. In addition, it cannot be a consequence of differ-
ences in the host genetic background since B6.IFN-γ-/-
mice show an increased parasitaemia and exhibit higher
mortality following P. chabaudi infection [9]. This suggests
that the parasite species likely accounts for these differ-
ences. In accordance with this latter hypothesis and also
with the results presented here, a recent report showed
that the control of the primary wave of P. yoelii 17× para-
sitaemia is independent of IFN-γ [13].
As the parasitaemia was lower in the absence of IFN-γ, this
suggests that IFN-γ would either facilitate P. yoelii's repli-
cation, and/or disadvantage its control by the immune
system. One possibility could be that IFN-γ favours the
parasitaemia through promoting the production of P. yoe-
lii's blood stage target cell, namely the reticulocyte. Fur-
ther investigations are required to address precisely the
mode of action of IFN-γ on the erythrocytic stage in this
model.
It is interesting to note that both the constitutive genetic
deficiency in IFN-γ and the in vivo neutralization withMalaria Journal 2009, 8:128 http://www.malariajournal.com/content/8/1/128
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anti-IFN-γ mAb delay the course of parasitaemia and
decrease the level of the parasite load. However, only the
constitutive deficiency of IFN-γ makes the parasitaemia
last longer. This latter observation is reminiscent of the
one made in B6 mice infected with P. chabaudi pRBCs,
showing that IFN-γ favours the appropriate antibody
response required to eliminate efficiently the blood-stage
parasites after day 20 of infection [24,25]. The results pre-
sented here thus argue in favour of two opposite roles
played by IFN-γ during P. yoelii primary infection in B6
mice: in the first days following sporozoites injection,
IFN-γ would be deleterious for the host as it favours the
parasitaemia, while, after the first week of infection, it
would be beneficial for the host, helping to clear effi-
ciently the blood-stage parasites. In addition, regarding
the role of IFN-γ early in infection, only the injection of
anti-IFN-γ Abs in B6 mice at day 3 p.i., two days before the
cytokine increases in the serum, lowered the parasitaemia
in all the treated mice. Injection of the same concentration
of antibody performed at days 5 or 7 p.i. had no effect on
the parasitaemia, and injection at day 4 p.i. lowered the
parasitaemia of approximatively half of the treated mice.
These results show that early immune events, occurring in
a very narrow window of time are crucial for the control
of the subsequent growth of P. yoelii in B6 mice. Moreo-
ver, these data reflect the importance of the timing and
quantity of the release of an inflammatory mediator, i.e.
in appropriate amounts at appropriate time during the
inflammatory response [26].
Regarding the cell types involved in this early burst of IFN-
γ it appears that conventional splenic CD4 T cells are
likely to be the main source of this cytokine at day 5 p.i..
These results are coherent with observations made in
infected B6.RAG2-/- mice (lacking T and B cells), which
showed no early peak of IFN-γ and exhibited a lower par-
asitaemia than B6 mice following injection of P. yoelii spo-
rozoites [11]. Nevertheless, the first cells to produce IFN-γ
are innate NK, NKT and γδT cells, which responded simul-
taneously, suggesting their concomitant activation. Fur-
ther investigations are required to determine whether this
IFN-γ response by innate and CD4 lymphocytes depends
on the pre-erythrocytic stage only, or both the pre-eryth-
rocytic and the erythrocytic stages.
It is also interesting to note that CD1d-restricted NKT cells
are not necessary for the initiation of this early production
of IFN-γ. Together with previously published results
showing that CD1d-independent NKT cells are induced in
the spleen of P. yoelii-infected B6 mice and are biased
towards the production of Th1-type cytokines [12], these
data strengthen the idea that CD1d-independent NKT
cells are involved in P. yoelii-induced early Th1 immune
response.
The concentration of IFN-γ in the blood rapidly decreased.
This could be due to its capture by target receptors and/or
to a quick shut down of its production by regulatory
mechanisms, such as TGF-β and/or IL-10 production
[13,27].
Finally, this early burst of IFN-γ was induced by the pre-
erythrocytic stage, showing the impact of this latter one on
the immune response taking place during the subsequent
blood stage.
Conclusion
Overall, the results presented here argue in favour of two
opposite roles for IFN-γ during P. yoelii primary infection
in B6 mice and show that an early IFN-γ response can be
deleterious for the host regarding the control of parasite
growth. Taken together with the recent report published
by Couper et al [13], these data challenge the prevailing
idea that IFN-γ is an essential mediator of protection in
malaria. These results also support the idea that the com-
mitment towards protection or pathology takes place very
early after infection since we show that precocious
immune events impact on the control of the parasite's
growth much later in infection.
Finally, these data highlight the complex regulation of the
primary immune response to P. yoelii sporozoite-induced
malaria, since it is shown that the pre-erythrocytic stage
induces an early burst of IFN-γ that, directly or indirectly,
favours parasitaemia. These results also strenghten the
need for studying the immune response to Plasmodium in
models closest as possible to the physiology of the natural
infection.
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